Travelers Institute Convenes Experts to Address Pandemic-Era Opioid Crisis
Retrieved on:
Monday, November 1, 2021
Consulting, Professional Services, Other Health, Health, General Health, Public Policy, Pharmaceutical, Mental Health, Public Policy, Government, Insurance, Finance, Suds, The Travelers Companies, Disease, Industry, Milken Institute, Association, Â, Korea Disease Control and Prevention Agency, TRV, NYSE, Public policy, Bangladesh Technical Education Board, Telehealth, Center, Cycle, Public health, Mental health, Chronic pain, COVID-19, Program, Solution, Psychiatry, Q&A, Population, Traveler, Prevalence, Ives, California Center for Public Health Advocacy, Medicine, Insurance
The Travelers Institute , the public policy division of The Travelers Companies, Inc. (NYSE: TRV ), will host a webinar on Wednesday, Nov. 3, titled The Pandemic-Era Opioid Crisis: Where Are We Now?
Key Points:
- The Travelers Institute , the public policy division of The Travelers Companies, Inc. (NYSE: TRV ), will host a webinar on Wednesday, Nov. 3, titled The Pandemic-Era Opioid Crisis: Where Are We Now?
- Spitaletta and Ives will provide remarks and then serve as panelists during a Q&A moderated by Joan Woodward, President of the Travelers Institute and Executive Vice President of Public Policy at Travelers.
- To learn more about the Travelers Institute and other upcoming events, please visit Travelers.com/Travelers-Institute .
- The Travelers Institute draws upon the industry expertise of Travelers senior management as well as the technical expertise of many of Travelers underwriters, risk managers and other experts to provide information, analysis and solutions to public policymakers and regulators.